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Table. Trends in open and endovascular interventions
for acute and chronic mesenteric ischemia utilization the
National Inpatient Sample (2000-2011)
Year Open Endovascular
Inhospital
Mortality, %
Length
of Stay
Total
Charges
(2011 USD)
2000 222 146 28.3 15.88 $114,984.45
2001 248 172 28.9 15.50 $112,189.12
2002 209 222 25.2 15.30 $116,062.17
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Volume 59, Number 6S Abstracts 53Selevated body mass index (BMI) to radiation exposure dur-
ing EVAR procedures.
Methods: Serially encountered patients who under-
went EVAR from September 2011 to December 2013
were identiﬁed. The population was divided into a high
BMI group ($26 kg/m2) and a low BMI group (<26
kg/m2). Patient demographics, operative times, number
of EVAR components used, adjunctive open/endovascular
procedures, contrast used, ﬂuoroscopy time, and radiation
exposure data were collected and analyzed.
Results: Sixty-two EVAR procedures were performed.
The high BMI group was signiﬁcantly younger than
the low BMI group (67 6 6 years vs 73 6 7 years,
P ¼ .0015; Wilcoxon two-sample rank test). Patient fac-
tors, including diabetes, hypertension, and smoking his-
tory, were not signiﬁcantly different between the two
cohorts. All patients were male.
Multiple linear regression models with step-wise selec-
tion of all variables identiﬁed four factorsdoperative time,
contrast used, ﬂuoroscopy time, and BMIdas signiﬁcant
predictors of increased radiation exposure levels.
Conclusions: Retrospective analysis of EVAR demon-
strates that patients with modestly elevated BMI had mark-
edly increased radiation exposure. This ﬁnding has patient
safety implications but also serves as a warning to providers
who are conducting EVARs in patients with elevated BMI.2003 229 295 23.7 14.29 $120,827.26
2004 257 361 20.4 14.22 $119,372.77
2005 197 374 19.8 13.62 $120,333.08
2006 244 491 16.5 12.43 $115,480.42
2007 224 453 17.8 11.50 $116,940.27
2008 275 548 17.3 13.57 $145,503.81
2009 245 593 13.7 12.47 $142,839.64
2010 260 648 14.5 12.10 $140,418.17
2011 295 684 17.3 11.90 $153,602.76
Table.
Variables (mean 6 SD)
Low BMI
(n ¼ 24)
High BMI
(n ¼ 36) Pa
BMI, kg/m2 23.1 6 2.0 31.4 6 4.5 <.0001
Operative time, min 144 6 30 155 6 30 .1365
EVAR components used, No. 2.8 6 0.7 2.8 6 0.8 .8823
Fluoroscopy time, min 19.5 6 8.2 19.7 6 10.4 .9194
Radiation exposure, mGy 380.6 6 240.4 670.7 6 430.3 .0007
aWilcoxon two-sample rank test.Author Disclosures: M. Amendola: Nothing to disclose;
M. Levy: Nothing to disclose; J. Pfeifer: Nothing to
disclose; L. Wolfe: Nothing to disclose; M. Woogen-
Fisher: Nothing to disclose.PS76.
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Objectives: The aim of this study was to evaluate na-
tional trends in screening for mesenteric ischemia and its
impact on the diagnosis and mortality.
Methods: A retrospective analysis of the cross-
sectional National Inpatient Sample (2000-2011) was
used to evaluate patients who underwent screening evalua-
tion for acute and chronic mesenteric ischemia, and this
was correlated with the number of open and endovascular
interventions, in-hospital mortality, length of stay, and to-
tal charges (2011 USD).
Results: The number of open interventions for mesen-
teric ischemia increased 33%, whereas endovascularinterventions increased by 468% over the study period.
Earlier diagnosis led to a decrease in acute mesenteric
ischemia from 62% in 2000 to 43% in 2011 (P < .05).
This was associated with a 64% decline in in-hospital mor-
tality (28.3% to 17.3%) and a decrease in median length of
stay from 11 to 8 days. During this period, noninvasive
screening for mesenteric ischemia increased by 73%. The
rate of bowel resection remained constant at 8.7%. Total
charges increased by 34% during the study period.
Conclusions: Increased use of noninvasive screening
for mesenteric ischemia is associated with earlier diagnosis,
an increase in open and endovascular interventions,
decreased length of stay, and decreased in-hospital mortal-
ity. However, the use of screening does not affect the rate
of complications after the intervention.Author Disclosures: S. S. Desai: Nothing to disclose; A.
Dua: Nothing to disclose.PS78.
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Objectives: Intravascular optical coherence tomogra-
phy (OCT) uses a ﬁberoptic catheter to generate a high-
resolution cross-sectional image of small blood vessels but
requires blood clearing. OCT is used in coronary vessels
to generate axial images superior to intravascular ultra-
sound (IVUS) or conventional angiography for
morphology assessment. This ﬁrst-in-man trial examines
OCT and determines the optimum ﬂush medium in lower
extremity OCT image capture.
Methods: The OPTical Imaging Measurement of
Intravascular Solution Efﬁcacy (OPTIMISE) Trial is a sin-
gle-center, prospective study. Twenty-eight patients were
recruited undergoing elective endovascular intervention
